

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.28417335 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.11750599 |
| 3 | exogenous drug catabolic process (GO:0042738) | 9.04979318 |
| 4 | drug catabolic process (GO:0042737) | 8.87638923 |
| 5 | glyoxylate metabolic process (GO:0046487) | 8.66631729 |
| 6 | complement activation, alternative pathway (GO:0006957) | 8.56406312 |
| 7 | regulation of fibrinolysis (GO:0051917) | 8.30506995 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.03744770 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 8.03744770 |
| 10 | regulation of protein activation cascade (GO:2000257) | 7.84616525 |
| 11 | ethanol oxidation (GO:0006069) | 7.69526781 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 7.67675667 |
| 13 | regulation of complement activation (GO:0030449) | 7.46600601 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 7.29414355 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.29414355 |
| 16 | urea metabolic process (GO:0019627) | 6.64790899 |
| 17 | fibrinolysis (GO:0042730) | 6.59154822 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.41566700 |
| 19 | protein carboxylation (GO:0018214) | 6.41566700 |
| 20 | drug metabolic process (GO:0017144) | 6.38638273 |
| 21 | ethanol metabolic process (GO:0006067) | 6.15115454 |
| 22 | imidazole-containing compound metabolic process (GO:0052803) | 6.14563011 |
| 23 | oxidative demethylation (GO:0070989) | 6.10734487 |
| 24 | blood coagulation, intrinsic pathway (GO:0007597) | 6.09526187 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 6.05225908 |
| 26 | cellular glucuronidation (GO:0052695) | 5.91215339 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 5.89811950 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.86755497 |
| 29 | negative regulation of sterol transport (GO:0032372) | 5.69201637 |
| 30 | negative regulation of cholesterol transport (GO:0032375) | 5.69201637 |
| 31 | urea cycle (GO:0000050) | 5.68459346 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.62122185 |
| 33 | uronic acid metabolic process (GO:0006063) | 5.59596650 |
| 34 | glucuronate metabolic process (GO:0019585) | 5.59596650 |
| 35 | bile acid biosynthetic process (GO:0006699) | 5.56263423 |
| 36 | regulation of plasminogen activation (GO:0010755) | 5.49626352 |
| 37 | phenylpropanoid metabolic process (GO:0009698) | 5.48844723 |
| 38 | protein activation cascade (GO:0072376) | 5.36897366 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 5.33494152 |
| 40 | glycine metabolic process (GO:0006544) | 5.21158204 |
| 41 | complement activation (GO:0006956) | 5.15377324 |
| 42 | complement activation, classical pathway (GO:0006958) | 5.02955526 |
| 43 | bile acid metabolic process (GO:0008206) | 5.02407428 |
| 44 | opsonization (GO:0008228) | 4.85871642 |
| 45 | negative regulation of protein activation cascade (GO:2000258) | 4.81517991 |
| 46 | bile acid and bile salt transport (GO:0015721) | 4.78211797 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.75507373 |
| 48 | negative regulation of hemostasis (GO:1900047) | 4.75507373 |
| 49 | S-adenosylmethionine metabolic process (GO:0046500) | 4.70355671 |
| 50 | regulation of humoral immune response (GO:0002920) | 4.68812854 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.63972649 |
| 52 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.50046438 |
| 53 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.50046438 |
| 54 | glutamate metabolic process (GO:0006536) | 4.49402363 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.42993919 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.42993919 |
| 57 | phospholipid efflux (GO:0033700) | 4.38975217 |
| 58 | acute-phase response (GO:0006953) | 4.38727516 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.30925549 |
| 60 | alkaloid metabolic process (GO:0009820) | 4.30232677 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27390658 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 4.27390658 |
| 63 | macromolecular complex remodeling (GO:0034367) | 4.27390658 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 4.25587222 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.25197937 |
| 66 | cytolysis (GO:0019835) | 4.23532463 |
| 67 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.19724223 |
| 68 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.19724223 |
| 69 | serine family amino acid metabolic process (GO:0009069) | 4.16650395 |
| 70 | high-density lipoprotein particle remodeling (GO:0034375) | 4.16370654 |
| 71 | negative regulation of complement activation (GO:0045916) | 4.16189222 |
| 72 | positive regulation of blood coagulation (GO:0030194) | 4.16165551 |
| 73 | positive regulation of hemostasis (GO:1900048) | 4.16165551 |
| 74 | cholesterol efflux (GO:0033344) | 4.15681133 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 4.04308144 |
| 76 | indolalkylamine catabolic process (GO:0046218) | 3.99649443 |
| 77 | tryptophan catabolic process (GO:0006569) | 3.99649443 |
| 78 | indole-containing compound catabolic process (GO:0042436) | 3.99649443 |
| 79 | aromatic amino acid family metabolic process (GO:0009072) | 3.99435602 |
| 80 | flavonoid metabolic process (GO:0009812) | 3.99032415 |
| 81 | arginine metabolic process (GO:0006525) | 3.98152541 |
| 82 | amino-acid betaine metabolic process (GO:0006577) | 3.89868053 |
| 83 | regulation of cholesterol esterification (GO:0010872) | 3.85841384 |
| 84 | reverse cholesterol transport (GO:0043691) | 3.82886141 |
| 85 | positive regulation of coagulation (GO:0050820) | 3.78846798 |
| 86 | hormone catabolic process (GO:0042447) | 3.77230546 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.74782385 |
| 88 | cellular amino acid catabolic process (GO:0009063) | 3.66230925 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.63463398 |
| 90 | intestinal cholesterol absorption (GO:0030299) | 3.62842253 |
| 91 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.62576445 |
| 92 | tryptophan metabolic process (GO:0006568) | 3.62526924 |
| 93 | sodium-independent organic anion transport (GO:0043252) | 3.60846603 |
| 94 | cysteine metabolic process (GO:0006534) | 3.60750772 |
| 95 | ketone body metabolic process (GO:1902224) | 3.54404132 |
| 96 | aldehyde catabolic process (GO:0046185) | 3.54062016 |
| 97 | xenobiotic metabolic process (GO:0006805) | 3.53148798 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 3.49529278 |
| 99 | heme transport (GO:0015886) | 3.42422951 |
| 100 | regulation of acute inflammatory response (GO:0002673) | 3.37137143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.28533949 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.93639209 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.77576106 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.54767836 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.37307723 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.66916288 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.32487199 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.65440449 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.55548903 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.00896430 |
| 11 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.08975579 |
| 12 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.04676601 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03862679 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.01661150 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9468882 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99871640 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67976470 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41916880 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40502643 |
| 20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.34885153 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29439330 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22023764 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15783393 |
| 24 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14374241 |
| 25 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10843494 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04976198 |
| 27 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.04550375 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01429791 |
| 29 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.99137114 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98259348 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96036146 |
| 32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95248662 |
| 33 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.94407015 |
| 34 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88517890 |
| 35 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88366506 |
| 36 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.88001897 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86861341 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86346434 |
| 39 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86178318 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82882282 |
| 41 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.82067190 |
| 42 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82031479 |
| 43 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.80949890 |
| 44 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.80639646 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79013987 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78907832 |
| 47 | NFYA_21822215_ChIP-Seq_K562_Human | 0.78382748 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78273219 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77533165 |
| 50 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.77411021 |
| 51 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.76532639 |
| 52 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.75243400 |
| 53 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74316179 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73409515 |
| 55 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73111067 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72844137 |
| 57 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72801531 |
| 58 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72576937 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.72175518 |
| 60 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.71229820 |
| 61 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.70565908 |
| 62 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.69128398 |
| 63 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.69120982 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.67364493 |
| 65 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.66842147 |
| 66 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.65878912 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.64938949 |
| 68 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64851176 |
| 69 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.64391851 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.63789964 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.63565868 |
| 72 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.61899794 |
| 73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.61899794 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60476331 |
| 75 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.60255684 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.59386995 |
| 77 | NFYB_21822215_ChIP-Seq_K562_Human | 0.58219931 |
| 78 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.58166229 |
| 79 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.58129545 |
| 80 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.57836180 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.56906459 |
| 82 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56802134 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.56565330 |
| 84 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.56261445 |
| 85 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.55236077 |
| 86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.54212347 |
| 87 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.54136103 |
| 88 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.54054236 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.53868705 |
| 90 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.53619686 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.52701258 |
| 92 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.52218224 |
| 93 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.51312808 |
| 94 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.51075578 |
| 95 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.51044044 |
| 96 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.50920700 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.50901995 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.50592035 |
| 99 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50489210 |
| 100 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.50423524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.41125616 |
| 2 | MP0005360_urolithiasis | 6.98309334 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27329036 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.76656771 |
| 5 | MP0003195_calcinosis | 5.37933399 |
| 6 | MP0005365_abnormal_bile_salt | 5.28277228 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.93932756 |
| 8 | MP0003252_abnormal_bile_duct | 4.04908306 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.05035952 |
| 10 | MP0003868_abnormal_feces_composition | 3.01546228 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.92115370 |
| 12 | MP0009697_abnormal_copulation | 2.92095966 |
| 13 | MP0005332_abnormal_amino_acid | 2.43375200 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.30663327 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.21216202 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.04905689 |
| 17 | MP0000609_abnormal_liver_physiology | 1.77103023 |
| 18 | MP0010368_abnormal_lymphatic_system | 1.73045044 |
| 19 | MP0009840_abnormal_foam_cell | 1.67219761 |
| 20 | MP0001764_abnormal_homeostasis | 1.66532706 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.66183247 |
| 22 | MP0001661_extended_life_span | 1.42996405 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.25839360 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.17211108 |
| 25 | MP0005408_hypopigmentation | 1.10603536 |
| 26 | MP0005670_abnormal_white_adipose | 1.09975910 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.07734627 |
| 28 | MP0000598_abnormal_liver_morphology | 1.04722077 |
| 29 | MP0002132_abnormal_respiratory_system | 1.04086547 |
| 30 | MP0009053_abnormal_anal_canal | 1.00186789 |
| 31 | MP0009643_abnormal_urine_homeostasis | 0.99427964 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94955184 |
| 33 | MP0009764_decreased_sensitivity_to | 0.94766975 |
| 34 | MP0002282_abnormal_trachea_morphology | 0.93082058 |
| 35 | MP0003186_abnormal_redox_activity | 0.89780125 |
| 36 | MP0005451_abnormal_body_composition | 0.88305500 |
| 37 | MP0003690_abnormal_glial_cell | 0.84959303 |
| 38 | MP0009763_increased_sensitivity_to | 0.84779292 |
| 39 | MP0008872_abnormal_physiological_respon | 0.83211627 |
| 40 | MP0002971_abnormal_brown_adipose | 0.82728122 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.82707428 |
| 42 | MP0005376_homeostasis/metabolism_phenot | 0.81888227 |
| 43 | MP0000604_amyloidosis | 0.77428448 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 0.77288096 |
| 45 | MP0008469_abnormal_protein_level | 0.76683406 |
| 46 | MP0005187_abnormal_penis_morphology | 0.76430157 |
| 47 | MP0001915_intracranial_hemorrhage | 0.76055744 |
| 48 | MP0005535_abnormal_body_temperature | 0.75857713 |
| 49 | MP0005395_other_phenotype | 0.75022981 |
| 50 | MP0003879_abnormal_hair_cell | 0.72752777 |
| 51 | MP0002168_other_aberrant_phenotype | 0.67743715 |
| 52 | MP0002249_abnormal_larynx_morphology | 0.65959367 |
| 53 | MP0005266_abnormal_metabolism | 0.65723367 |
| 54 | MP0003011_delayed_dark_adaptation | 0.62827815 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 0.60709274 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 0.58394589 |
| 57 | MP0005334_abnormal_fat_pad | 0.58185559 |
| 58 | MP0003638_abnormal_response/metabolism_ | 0.57477302 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 0.57336485 |
| 60 | MP0008874_decreased_physiological_sensi | 0.54631701 |
| 61 | MP0009785_altered_susceptibility_to | 0.48556169 |
| 62 | MP0005464_abnormal_platelet_physiology | 0.47660989 |
| 63 | MP0005166_decreased_susceptibility_to | 0.46122598 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 0.44925235 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 0.44222597 |
| 66 | MP0000566_synostosis | 0.43964695 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.42947462 |
| 68 | MP0003075_altered_response_to | 0.42702245 |
| 69 | MP0000249_abnormal_blood_vessel | 0.41145371 |
| 70 | MP0005448_abnormal_energy_balance | 0.40827324 |
| 71 | MP0004130_abnormal_muscle_cell | 0.40302888 |
| 72 | MP0001986_abnormal_taste_sensitivity | 0.39067259 |
| 73 | MP0004883_abnormal_blood_vessel | 0.36556380 |
| 74 | MP0002332_abnormal_exercise_endurance | 0.35528337 |
| 75 | MP0003718_maternal_effect | 0.35231508 |
| 76 | MP0005023_abnormal_wound_healing | 0.34616422 |
| 77 | MP0003953_abnormal_hormone_level | 0.31496981 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 0.29449330 |
| 79 | MP0000639_abnormal_adrenal_gland | 0.29272177 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.28842047 |
| 81 | MP0002928_abnormal_bile_duct | 0.28144302 |
| 82 | MP0001545_abnormal_hematopoietic_system | 0.26066443 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.26066443 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.26047381 |
| 85 | MP0005164_abnormal_response_to | 0.25641761 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.24761716 |
| 87 | MP0001440_abnormal_grooming_behavior | 0.23029755 |
| 88 | MP0009115_abnormal_fat_cell | 0.22569218 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 0.22408208 |
| 90 | MP0003633_abnormal_nervous_system | 0.22346135 |
| 91 | MP0003632_abnormal_nervous_system | 0.20724612 |
| 92 | MP0000467_abnormal_esophagus_morphology | 0.20444748 |
| 93 | MP0005647_abnormal_sex_gland | 0.20217015 |
| 94 | MP0003631_nervous_system_phenotype | 0.18953301 |
| 95 | MP0005646_abnormal_pituitary_gland | 0.18836570 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.18179922 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.17065472 |
| 98 | MP0004924_abnormal_behavior | 0.17065472 |
| 99 | MP0001756_abnormal_urination | 0.16210341 |
| 100 | MP0005197_abnormal_uvea_morphology | 0.15822729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.32771847 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.69848533 |
| 3 | Abnormality of complement system (HP:0005339) | 8.04970114 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.10052941 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 6.71539006 |
| 6 | Joint hemorrhage (HP:0005261) | 6.47103690 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 6.34775756 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.76179884 |
| 9 | Glomerulonephritis (HP:0000099) | 5.51718043 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 5.24989076 |
| 11 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.99116417 |
| 12 | Xanthomatosis (HP:0000991) | 4.87981028 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.84670847 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.29959294 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.21983675 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 4.09013165 |
| 17 | Nephritis (HP:0000123) | 3.95521426 |
| 18 | Spontaneous abortion (HP:0005268) | 3.93735315 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77252219 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.75970124 |
| 21 | Fair hair (HP:0002286) | 3.56119438 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.34114019 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.27322574 |
| 24 | Hyperglycinemia (HP:0002154) | 3.25289882 |
| 25 | Hyperammonemia (HP:0001987) | 3.14411653 |
| 26 | Neonatal hypoglycemia (HP:0001998) | 3.10261863 |
| 27 | Delayed CNS myelination (HP:0002188) | 3.09474779 |
| 28 | Fat malabsorption (HP:0002630) | 3.04825686 |
| 29 | Hypercholesterolemia (HP:0003124) | 2.99755097 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 2.88961605 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.88961605 |
| 32 | Mitral stenosis (HP:0001718) | 2.84626049 |
| 33 | Gingival bleeding (HP:0000225) | 2.79188156 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.77236400 |
| 35 | Epidermoid cyst (HP:0200040) | 2.74256211 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 2.69803089 |
| 37 | Hemorrhage of the eye (HP:0011885) | 2.69749788 |
| 38 | Vascular calcification (HP:0004934) | 2.63383277 |
| 39 | Cholecystitis (HP:0001082) | 2.63293695 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.63293695 |
| 41 | Thrombophlebitis (HP:0004418) | 2.61525974 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.58257092 |
| 43 | Hyperbilirubinemia (HP:0002904) | 2.58215858 |
| 44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.58096692 |
| 45 | Rickets (HP:0002748) | 2.53653754 |
| 46 | Pulmonary embolism (HP:0002204) | 2.52996632 |
| 47 | Purpura (HP:0000979) | 2.52237714 |
| 48 | Generalized hypopigmentation of hair (HP:0011358) | 2.50519097 |
| 49 | Osteomalacia (HP:0002749) | 2.46552677 |
| 50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.40495483 |
| 51 | Menorrhagia (HP:0000132) | 2.36974170 |
| 52 | Hyperglycinuria (HP:0003108) | 2.32266904 |
| 53 | Steatorrhea (HP:0002570) | 2.31668357 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.30715542 |
| 55 | Ketosis (HP:0001946) | 2.28591170 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.25400439 |
| 57 | Cholelithiasis (HP:0001081) | 2.23341577 |
| 58 | Metabolic acidosis (HP:0001942) | 2.22672113 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.20585295 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.11178080 |
| 61 | Blue irides (HP:0000635) | 2.04226154 |
| 62 | Elevated alkaline phosphatase (HP:0003155) | 2.03018635 |
| 63 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.5012994 |
| 64 | Deep venous thrombosis (HP:0002625) | 10.0595051 |
| 65 | Complement deficiency (HP:0004431) | 10.0468228 |
| 66 | Arthropathy (HP:0003040) | 1.95416862 |
| 67 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93175624 |
| 68 | Myocardial infarction (HP:0001658) | 1.92353625 |
| 69 | Abnormality of vitamin metabolism (HP:0100508) | 1.89706247 |
| 70 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88588807 |
| 71 | Hyperphosphaturia (HP:0003109) | 1.88317184 |
| 72 | Irritability (HP:0000737) | 1.88095023 |
| 73 | Gangrene (HP:0100758) | 1.80737123 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 1.76485132 |
| 75 | Abnormality of the Achilles tendon (HP:0005109) | 1.75212555 |
| 76 | Abnormal biliary tract physiology (HP:0012439) | 1.74932066 |
| 77 | Bile duct proliferation (HP:0001408) | 1.74932066 |
| 78 | Hypophosphatemic rickets (HP:0004912) | 1.74630913 |
| 79 | Joint swelling (HP:0001386) | 1.73367297 |
| 80 | Cerebral palsy (HP:0100021) | 1.72036021 |
| 81 | Increased mean platelet volume (HP:0011877) | 1.71484147 |
| 82 | Increased serum ferritin (HP:0003281) | 1.69388251 |
| 83 | Lethargy (HP:0001254) | 1.67712477 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 1.67378253 |
| 85 | Poikilocytosis (HP:0004447) | 1.67232866 |
| 86 | Epistaxis (HP:0000421) | 1.65700808 |
| 87 | Bifid scrotum (HP:0000048) | 1.65617162 |
| 88 | Alkalosis (HP:0001948) | 1.64925741 |
| 89 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.64441131 |
| 90 | Glycosuria (HP:0003076) | 1.63832168 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 1.63832168 |
| 92 | Atrioventricular block (HP:0001678) | 1.60464118 |
| 93 | Pancreatitis (HP:0001733) | 1.58550906 |
| 94 | Skin nodule (HP:0200036) | 1.57786196 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 1.55571712 |
| 96 | Cerebral edema (HP:0002181) | 1.54181587 |
| 97 | Abnormal platelet volume (HP:0011876) | 1.53676727 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 1.53273849 |
| 99 | Hydroxyprolinuria (HP:0003080) | 1.53273849 |
| 100 | Reticulocytosis (HP:0001923) | 1.51611321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.68574376 |
| 2 | ERN1 | 4.43549871 |
| 3 | BMPR1B | 3.78593916 |
| 4 | PIK3CG | 3.42909928 |
| 5 | GRK1 | 2.94873679 |
| 6 | FGFR4 | 2.92026259 |
| 7 | CDK8 | 2.80966894 |
| 8 | SIK1 | 2.53077764 |
| 9 | NTRK3 | 2.27680779 |
| 10 | EPHA4 | 2.26586185 |
| 11 | PRKACG | 2.10395915 |
| 12 | PIK3CA | 2.06790162 |
| 13 | TNK2 | 1.93378098 |
| 14 | TYK2 | 1.87901186 |
| 15 | MAP3K3 | 1.82001944 |
| 16 | KIT | 1.63381948 |
| 17 | TRIB3 | 1.62430418 |
| 18 | TGFBR1 | 1.58955767 |
| 19 | INSRR | 1.51079391 |
| 20 | PRKCG | 1.46900774 |
| 21 | NEK9 | 1.46559356 |
| 22 | PRKAA2 | 1.45574224 |
| 23 | MET | 1.43834386 |
| 24 | RIPK1 | 1.42829695 |
| 25 | MAP2K4 | 1.39614432 |
| 26 | FRK | 1.35874712 |
| 27 | EPHA3 | 1.33778928 |
| 28 | FGFR3 | 1.28641183 |
| 29 | TAOK3 | 1.26126519 |
| 30 | MAPK11 | 1.24695510 |
| 31 | IGF1R | 1.21736261 |
| 32 | ADRBK2 | 1.20855086 |
| 33 | AKT3 | 1.14603986 |
| 34 | FER | 1.12878033 |
| 35 | DAPK2 | 1.08126637 |
| 36 | MUSK | 1.03123693 |
| 37 | ARAF | 1.00270173 |
| 38 | JAK1 | 0.99526058 |
| 39 | PRKG1 | 0.98296957 |
| 40 | PRKAA1 | 0.97635670 |
| 41 | CDK9 | 0.95547296 |
| 42 | FLT3 | 0.95411890 |
| 43 | PDPK1 | 0.94960562 |
| 44 | ERBB2 | 0.92455747 |
| 45 | PRKACA | 0.90048356 |
| 46 | ICK | 0.89440475 |
| 47 | ABL2 | 0.89095294 |
| 48 | PRKCZ | 0.86148641 |
| 49 | PDK1 | 0.85549028 |
| 50 | PRPF4B | 0.82581835 |
| 51 | CAMKK2 | 0.81370795 |
| 52 | DYRK1B | 0.78446598 |
| 53 | MAP3K1 | 0.76937787 |
| 54 | TBK1 | 0.76519742 |
| 55 | CSF1R | 0.75995107 |
| 56 | MST1R | 0.72622662 |
| 57 | MAP3K9 | 0.72246767 |
| 58 | SGK1 | 0.70791013 |
| 59 | NLK | 0.68116549 |
| 60 | PRKCA | 0.65990298 |
| 61 | PKN2 | 0.62044666 |
| 62 | CSNK1D | 0.61505895 |
| 63 | RPS6KA3 | 0.61464579 |
| 64 | JAK2 | 0.57983127 |
| 65 | TIE1 | 0.56713069 |
| 66 | CSNK1E | 0.55413151 |
| 67 | PRKCE | 0.54977391 |
| 68 | MAP3K13 | 0.52754238 |
| 69 | PRKCB | 0.52116384 |
| 70 | PRKACB | 0.51959821 |
| 71 | WNK3 | 0.51357137 |
| 72 | DYRK1A | 0.50643050 |
| 73 | MAP3K11 | 0.50212926 |
| 74 | SGK223 | 0.49813094 |
| 75 | SGK494 | 0.49813094 |
| 76 | PAK3 | 0.49307046 |
| 77 | KDR | 0.48866149 |
| 78 | ERBB3 | 0.48408409 |
| 79 | PDK2 | 0.47563689 |
| 80 | CAMKK1 | 0.47404641 |
| 81 | CSNK1A1 | 0.45170452 |
| 82 | CDK7 | 0.44735901 |
| 83 | CAMK4 | 0.42048671 |
| 84 | SRC | 0.41146607 |
| 85 | TRPM7 | 0.41032734 |
| 86 | TAOK2 | 0.40792939 |
| 87 | MAP3K2 | 0.40179322 |
| 88 | SGK2 | 0.38949669 |
| 89 | BCR | 0.38497974 |
| 90 | MAPK4 | 0.36738132 |
| 91 | CSNK2A1 | 0.35815123 |
| 92 | FGFR2 | 0.35723846 |
| 93 | PINK1 | 0.35493425 |
| 94 | MYLK | 0.34208525 |
| 95 | CDK6 | 0.33880773 |
| 96 | CSNK2A2 | 0.33716302 |
| 97 | SGK3 | 0.33194696 |
| 98 | MAPK3 | 0.33091079 |
| 99 | MAPK10 | 0.31113900 |
| 100 | MAPK12 | 0.30612855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.13636279 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.11063477 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.00456108 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.63199854 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.61032774 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.58500801 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.46350914 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.00393488 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.98435618 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.91474271 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.73385319 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65987622 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.65680137 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.59030115 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.48731792 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.47878975 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.41601444 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.19015206 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.13581902 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.86470565 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80310135 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.75098263 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.73104755 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.70768427 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55250880 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.53721573 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49379185 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43131558 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42508461 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29551713 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28825621 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.26391909 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.26092444 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22667184 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21513509 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20074499 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14343751 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12974254 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10290138 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06585402 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03759994 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97436651 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97036122 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92159282 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91175732 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.83119824 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82735924 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81141228 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79711994 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77792718 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68322926 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66762112 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65083673 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61925308 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59278696 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55614353 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.44157628 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42450633 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38774736 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.37658088 |
| 61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24747377 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23476205 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.21473540 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20432101 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20255182 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16797959 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16431793 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12822642 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.08130888 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.05750803 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.04050432 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03176846 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.01601072 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.01496802 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.01323741 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01314542 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.01257927 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.00765233 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.00090439 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2788539 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2653834 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2568230 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2420555 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2408274 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2367554 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2208164 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.2023077 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1980676 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1894879 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1626714 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1437269 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1257485 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1194355 |
| 94 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.0936911 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0928881 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0856427 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | -0.0764242 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0603150 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0585674 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0585298 |

